14,000-strong people’s petition striving to save RNSH

Sydney’s Royal North Shore Hospital (RNSH) lobbyists are uniting in a last-ditch attempt to save RNSH from an under-funded and impractical redevelopment plan, recently presenting the local member for Willoughby, Gladys Berejiklian MP, a people’s petition comprising more than 14,000 signatories. Ms Berejiklian will be required to table the ‘people’s petition’ for ‘urgent debate’ in…

GLOBALHealthPR announces its first annual International Healthcare Social Media Summit

Communications specialists across the globe demonstrate how evaluating the digital conversation with smart listening leads to improved health communications GLOBALHealthPR, the largest independent public relations organisation dedicated exclusively to health and medical communications worldwide, announced today the organisation’s first International Healthcare Social Media Summit (IHSMS), set for May 18, 2011 in Washington, D.C. The event…

Australian health & wellness PR agency joins strategic global network

VIVA! Communications has joined GLOBALHealthPR – a strategic network of 14 independently owned PR agencies comprising more than 200 healthcare communication specialists spanning Asia-Pacific, the Americas and Europe.

Seeking multitalented communications consultant / Account Manager for health & wellness PR agency

VIVA! Communications is a dynamic, strategic and independent health and wellness Public Relations agency based in Sydney. We specialise in delivering award-winning counsel to the local and international medical, pharmaceutical (medicines and devices), biotech and community health and wellness sectors. We are seeking an ambitious, talented PR consultant / Account Manager with experience in healthcare…

Seeking high-performing communications graduate to join health & wellness PR agency

VIVA! Communications is a dynamic, strategic and independent health and wellness Public Relations agency based in Sydney seeking an ambitious and talented communications graduate to join our team on a full-time basis. Preferred skills set: Journalism/Communications/Public Relations, science and / or medical degree (mandatory) Some work experience in a PR agency (ideal) Some journalism/writing experience…

RNSH staff unite in last ditch attempt to counter flawed redevelopment plans

All quiet on the Labor front today, despite an unprecedented move by the Royal North Shore Hospital (RNSH) Medical Staff Council (MSC) to put the current ‘bed block bedlam’ to rest.  The 350-strong RNSH MSC convened a meeting today to bolster their opposition to the NSW government’s grossly under-funded and exceedingly flawed hospital redevelopment.  Dr…

Staff uniting to combat ‘bed block bedlam’ at RNSH

The 350-strong membership of the Royal North Shore Hospital (RNSH) Medical Staff Council (MSC) convened an extraordinary staff meeting today (Wednesday, March 16) to oppose the New South Wales government’s grossly under-funded and exceedingly flawed hospital redevelopment plans. With the NSW election now only 10 days away, the MSC held a staff meeting that attracted…

Staff uniting to combat ‘bed block bedlam’ at RNSH

The 350-strong membership of the Royal North Shore Hospital (RNSH) Medical Staff Council (MSC) will bolster its opposition to the New South Wales government’s grossly under-funded and exceedingly flawed hospital redevelopment plans tomorrow (Wednesday, March 16), at an extraordinary staff meeting to be held in the Kolling Institute auditorium at 1pm. With the NSW election…

Shortcuts to a leaner future: surgical solutions to mild cases of obesity are on the rise

HEALTH product giant Allergan has announced it will follow Australia’s lead and market its stomach-shrinking Lap-Band to US doctors treating people at the low end of the obesity scale. Until now, US physicians used the surgically implanted device only for seriously obese people, although it has been used for more than a decade to treat…

Newborns suffering from ultra-rare and fatal genetic disorder now have chance at life

Newborns with the ultra-rare and fatal genetic disorder – molybdenum cofactor deficiency (MoCD) Type A – now have a chance at life after Alexion Pharmaceuticals, Inc. purchased the assets and patents from Orphatec Pharmaceuticals GmbH, in order to accelerate the development of an investigational therapy to cure the fatal disorder.  MoCD Type A is characterised…